The venture capital (VC) funding landscape in the UK has demonstrated notable resilience in terms of value during early 2025, despite experiencing a decline in deal volume. The UK recorded a decrease of around 13% in VC deal volume during January-April 2025 compared to the same period in the previous year. Meanwhile, the UK’s VC funding value saw a more positive trajectory, with an increase of approximately 31% year-on-year (YoY), according to GlobalData, a leading data and analytics company.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The divergence between deal volume and value suggests that while fewer deals are being made, some are of significantly higher value, indicating a shift towards larger, more mature startups. Moreover, the pattern mirrors a broader trend observed across some other major markets, such as the US, where investors are becoming increasingly selective in their funding choices.”

The UK’s ability to attract high-value investments is a testament to investor confidence in the startup ecosystem. Some of the notable VC funding deals announced in the UK during January-April 2025 include $600 million fundraising by Isomorphic Labs, $411 million raised by Verdiva Bio, and $300 million raised by Rapyd, among others.

An analysis of GlobalData’s Deals Database revealed that the UK accounted for around 7% of the total number of VC deals announced globally during January-April 2025, while its share of the corresponding funding value was around 4%.

Bose concludes: “As the global investment climate continues to evolve, the UK market has managed to maintain a significant presence and currently stands among the top five markets for VC funding activity in the world in terms of both deal volume and value.”

Note: Historic data may change in case some deals get added to previous months because of a delay in disclosure of information in the public domain